CHRIS A. RALLIS
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
KEN BRIGHT, DAVID CAVALIER, DAVID C. CAVALIER, JOHN M. CLERICI, BRIAN DAY, JOHN FARAH, JOHN M. FARAH, JR., MITCHELL D. KAYE, JOSEPH KRIVULKA, JOSEPH J. KRIVULKA, AMIT KUMAR, MICHAEL LEWIS, MICHAEL E. LEWIS, JOHN MCMANUS, JOHN L. MCMANUS, MICHAEL MCMANUS, CHRIS RALLIS, JEFFREY A. SCOTT, RUSSELL SKIBSTED, PETER SUZDAK, PETER D. SUZKAK
DIRECTOR
JUNE ALMENOFF, RONALD R BLANCK, RONALD R. BLANCK, STEVEN BOYD, WILLIAM A CHATFIELD, WILLIAM A. CHATFIELD, MICHAEL DAVIDSON, ANTHONY DITONNO, ANTHONY A DITONNO, ANTHONY A. DITONNO, DECLAN DOOGAN, MELVILLE ENGLE, CHRISTOPHER T. GIORDANO, LAWRENCE R. HOFFMAN, ROBYN HUNTER, ROBYN M. HUNTER, MICHAEL JEBSEN, MICHAEL B JEBSEN, MICHAEL B. JEBSEN, JOHN KELLEY, RICHARD KIRAL, GERALD KLEIN, ELIOT LURIER, KEITH MAHER, JAMES MITCHUM, GREGORY PEPIN, GERALD PROEHL, GERALD T. PROEHL, CHRIS A RALLIS, STUART RICH, CHARLES SEEMAN, BRUCE SPIESS, CHRIS STERN
DIRECTOR
DIRECTOR
JUNE ALMENOFF, RONALD R BLANCK, RONALD R. BLANCK, STEVEN BOYD, WILLIAM A CHATFIELD, WILLIAM A. CHATFIELD, MICHAEL DAVIDSON, ANTHONY DITONNO, ANTHONY A DITONNO, ANTHONY A. DITONNO, DECLAN DOOGAN, MELVILLE ENGLE, CHRISTOPHER T. GIORDANO, LAWRENCE R. HOFFMAN, ROBYN HUNTER, ROBYN M. HUNTER, MICHAEL JEBSEN, MICHAEL B JEBSEN, MICHAEL B. JEBSEN, JOHN KELLEY, RICHARD KIRAL, GERALD KLEIN, ELIOT LURIER, KEITH MAHER, JAMES MITCHUM, GREGORY PEPIN, GERALD PROEHL, GERALD T. PROEHL, CHRIS A RALLIS, STUART RICH, CHARLES SEEMAN, BRUCE SPIESS, CHRIS STERN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
2020-07-08
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
2020-03-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-12-10
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2013-11-22
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
$1,000,001 - $5,000,000
Equity
2013-08-22
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
$1,000,001 - $5,000,000
Equity
2013-07-23
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
$1 - $1,000,000
Equity
2013-02-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-02-22
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-04-04

